EHR Time Improves Quality; Low-Cost Colon Cancer Screening; Tumors From 3D Printers

A study of 291 primary care physicians showed that devoting more time to electronic health records (EHRs) was associated with improvements in several quality indicators, including breast cancer screening. (Brigham and Women’s Hospital, JAMA Network Open)

Exercise during and after chemotherapy improved cardiorespiratory fitness in patients with cancer. (JACC CardioOncology)

Two at-home screening tests for colorectal cancer — fecal immunohistochemistry testing (FIT) and DNA testing (Cologuard) — had similar rates of cancer detection, but FIT achieved results at a substantially lower cost. (American College of Surgeons)

A subgroup analysis of a randomized trial showed that adjuvant nivolumab (Opdivo) significantly improved recurrence-free survival in stage IIB/C melanoma, according to a statement from Bristol Myers Squibb.

In a first-of-its-kind study, researchers used 3D printers to produce breast cancers, and then treated the tumor models. (Penn State)

John Jarcho, MD, deputy editor of cardiology for the New England Journal of Medicine, died October 13 of pancreatic cancer.

Breast cancers diagnosed within 5 years of pregnancy have a significantly increased risk of metastasis. (OHSU Knight Cancer Institute, JAMA Network Open)

The FDA has published new guidance for tissue-agnostic drug development in oncology.

An experimental therapy that combines chemotherapy and a radioactive isotope eradicated 80% of pancreatic tumors in mice. (Duke University, Nature Biomedical Engineering)

The American Society for Radiation Oncology annual meeting begins this weekend and continues through next Wednesday. MedPage Today will have complete coverage.